[A05-20C] Bupropion, mirtazapine, and reboxetine in the treatment of depression

Last updated 01.06.2011

Project no.:
A05-20C

Commission:
Commission awarded on 22.02.2005 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Mental and emotional wellbeing

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form